- PARP inhibitors in the therapy of ovarian cancer2019 | Faculty of Medicine in Pilsen
- Olaparib - the first PARP inhibitor in the treatment of malignant tumors2015 | First Faculty of Medicine
- PARP inhibitors in treating metastatic castration-resistant prostate cancer2023 | First Faculty of Medicine
- Inhibitory PARP - nová naděje pro pacientky s epiteliálním karcinomem ovaria2019 | Faculty of Medicine in Hradec Králové
- Současné indikace k léčbě inhibitory PARP u pacientek s karcinomem ovarií/vejcovodu2022 | First Faculty of Medicine
- The use of niraparib in the treatment of ovarian cancer2023 | First Faculty of Medicine
- PARP inhibitor olaparib and anti-VEGF bevacizumab - targeted treatment and efforts to improve the outcome of patients with advanced tuboovarian cancer2020 | Faculty of Medicine in Pilsen
- Niraparib as maintenance therapy after primary treatment of ovarian cancer - a case report2023 | First Faculty of Medicine
- PARP inhibitor olaparib great benefit for a defined group of patients with BRCA positive ovarian cancer2019 | Faculty of Medicine in Pilsen
- BRCA1 and BRCA2 - pathologist's starting kit2016 | Second Faculty of Medicine
- WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors2019 | Central Library of Charles University
- Platinum-sensitive recurrent ovarian cancer and olaparib maintenance treatment - case report2019 | First Faculty of Medicine
- Léčba platina-senzitivního recidivujícího karcinomu vaječníků s užitím inhibitoru PARP olaparibu2018 | First Faculty of Medicine
- olaparib2017 | First Faculty of Medicine
- PARP inhibitors in ovarian cancer FOREWORD2015 | First Faculty of Medicine
- Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?2010 | Faculty of Medicine in Pilsen
- Niraparib2021 | First Faculty of Medicine
- Nové možnosti léčby pacientek s mutacemi genů BRCA1/2 a karcinomem ovarií2017 | First Faculty of Medicine
- Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum2016 | First Faculty of Medicine, Second Faculty of Medicine
- Methadone Potentiates the Cytotoxicity of Temozolomide by Impairing Calcium Homeostasis and Dysregulation of PARP in Glioblastoma Cells2023 | Faculty of Science
- The SC-35 Splicing Factor Interacts with RNA Pol II and A-Type Lamin Depletion Weakens This Interaction2021 | First Faculty of Medicine
- Mycotoxins have a potential of inducing cell senescence: A new understanding of mycotoxin immunotoxicity2023 | Publication without faculty affiliation
- Changes in Expression of Some Apoptotic Markers in Different Types of Human Endometrium2011 | Faculty of Science, First Faculty of Medicine
- Benefit of olaparib in the treatment of ovarian cancer – clinical practice2023 | Third Faculty of Medicine
- Pokročilý triple negativní karcinom prsu2017 | First Faculty of Medicine
- News in the targeted biological treatment of breast cancer2011 | First Faculty of Medicine
- Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma2019 | Faculty of Medicine in Pilsen
- Olaparib as a maintenance therapy in newly diagnosed patients with ovarian cancer - SOLO1 study results2022 | Third Faculty of Medicine
- Sou časné možnosti a výhledy léčby pacientek s karcinomem prsu2021 | First Faculty of Medicine
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
